Foresight Group (Foresight), a listed private equity and infrastructure investment manager, has made an additional GBP3.5 million investment into Hospital Services Limited (HSL). Established in 1962, and based in Belfast, with additional offices in Dublin and East Midlands, HSL is a specialist distributor of diagnostic medical devices, surgical equipment and
CORL Technologies, a provider of vendor risk management solutions for the healthcare industry, has secured a strategic growth investment from Primus Capital, a growth-oriented private equity firm focused on investing in healthcare, software, and technology-enabled services companies. The partnership will allow CORL to accelerate its growth trajectory and continue its
Meditology Services, a provider of information risk management, cybersecurity, privacy, and regulatory compliance services for the healthcare industry, has secured a strategic growth investment from Primus Capital, a growth-oriented private equity firm focused on investing in healthcare, software, and technology-enabled services companies. Founded in 2010, Meditology provides a broad array
Future Fertility, a fertility technology company developing AI-enabled and non-invasive fertility solutions to optimise clinical decision making in fertility care and in vitro fertilisation (IVF), has closed a Series A financing round led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany, a global fertility leader).
Symplr, a specialist in enterprise healthcare operations including governance, risk management, and compliance (GRC) software-as-a-service (SaaS) solutions, backed by Clearlake Capital Group, and Charlesbank Capital Partners has raised new capital via a Clearlake-managed dedicated fund, Icon Partners V (Icon V). In addition to broadening symplr’s investor base, the transaction provides
Smile Doctors, a US-based, orthodontics-focused dental support organization (OSO), has secured a strategic investment from Thomas H Lee Partners (THL), a private equity firm investing in growth companies. THL is investing alongside existing financial sponsor Linden Capital Partners (Linden) in an equal partnership, while affiliated orthodontists will retain a significant
Castlight Health, a healthcare data and navigation company, and Vera Whole Health (Vera), a specialist in advanced primary caremajority owned by Clayton, Dubilier & Rice (CD&R), are to merge. The transaction, which has been unanimously approved by Castlight’s Board of Directors, is valued at an equity value of approximately USD370
symplr, a specialist in enterprise healthcare operations including governance, risk management, and compliance (GRC) SaaS solutions, backed by Clearlake Capital Group and Charlesbank Capital Partners, has agreed to acquire Midas Health Analytics Solutions (Midas) from Conduent Incorporated (Conduent). The transaction is expected to close in the first quarter of 2022,
Script, a specialist in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, has completed its Series C financing, raising USD200 million of new capital. With this latest financing, DNA Script has raised USD315 million since the company was founded in 2014. Accounts and funds advised by T Rowe Price Associates
Nordstjernan is investing in Ascilion, a Swedish medtech company founded in 2012 and based in Stockholm, Sweden. Ascilion has developed and patented a technology that uses an array of hollow microneedles to extract the interstitial fluid (ISF) that surrounds the body’s cells and that is a good carrier of biomarkers.
12 September, 2024 – 6:00 pm
05 June, 2024 – 8:30 am
24 October, 2024 – 8:30 am
14 November, 2024 – 8:00 am
